N. Takahashi et al., HYPERTROPHIC STIMULI INDUCE TRANSFORMING GROWTH FACTOR-BETA(1) EXPRESSION IN RAT VENTRICULAR MYOCYTES, The Journal of clinical investigation, 94(4), 1994, pp. 1470-1476
Transforming growth factor-beta(1) (TGF-beta(1)) is a peptide growth f
actor that may play a role in the myocardial response to hypertrophic
stimuli. However, the cellular distribution, mechanism of induction, a
nd source of increased TGF-beta(1) in response to hypertrophic stimuli
are not known. We tested the hypothesis that the cardiac myocyte resp
onds to hypertrophic stimuli with the increased expression of TGF-beta
(1). In adult rat ventricular myocardium freshly dissociated into myoc
yte and nonmyocyte cellular fractions, the preponderance of TGF-beta(1
) mRNA visualized by Northern hybridization was in the nonmyocyte frac
tion. Abdominal aortic constriction (7 d) and subcutaneous norepinephr
ine infusion (36 h) each caused ventricular hypertrophy associated wit
h 3.1-fold and 3.8-fold increases, respectively, in TGF-beta(1) mRNA i
n the myocyte fraction, but had no effect on the level of TGF-beta(1)
mRNA in the nonmyocyte fraction. In ventricular myocytes, norepinephri
ne likewise caused a 4.1-fold increase in TGF-beta(1) mRNA associated
with an increase in TGF-beta bioactivity. This induction of TGF-beta(1
) mRNA occurred at norepinephrine concentrations as low as 1 nM and wa
s blocked by prazosin, but not propranolol. NE did not increase the TG
F-beta(1) mRNA level in nonmyocytes, primarily fibroblasts, cultured f
rom neonatal rat ventricle. Thus, the cardiac myocyte responds to two
hypertrophic stimuli, pressure overload and norepinephrine, with the i
nduction of TGF-beta(1). These data support the view that TGF-beta(1),
released by myocytes and acting in an autocrine and/or paracrine mann
er, is involved in myocardial remodeling by hypertrophic stimuli.